MedPath

Prilocaine for Sphenopalatine Ganglion Block in Endoscopic Hypophysectomy

Not Applicable
Not yet recruiting
Conditions
Blood Pressure Control
Registration Number
NCT07188987
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

Patients undergoing endoscopic surgeries for pituitary adenoma excision suffer from wide swings in blood pressure that might increase bleeding and interfere with the surgical field.

Local anethetic infiltration and regional nerve blocks have been used to provide better analgesia, control blood pressure and improve surgical field.

Limited studies evaluated shenopalatine ganglion block in pituitary adenoma excision with promising outcomes. The proposed study will compare the efficacy of two local anesthetics, prilocaine and lidocaine, for spenopalatine ganglion block in patients undergoing endoscopic pituitary adenoma excision. Evaluating the control of the intraoperative blood pressure and analgesic sparing are the main objectives of the proposed study.

Detailed Description

Pituitary adenoma excision through endoscopic sinus surgery has been evolving over the years. Though less traumatic less traumatic and less invasive than other approaches, hemodynamic variations during several phases of the surgey as nasal dissection pose challenges for anesthesiologists.

Regional techniques present appealing options for better control of blood pressure during periods of maximal surgical stimulation, they may as well provide a better surgical field. One of the regional techniques is the sphenopalatine ganglion bock where a local anesthetic is injected in the pterygopalatine fossa around the sphenopalatine ganglion. Thus, It blocks pain transmission through the branches of the trigeminal nerve.

The current study was designed to compare the effects of two local anesthetics, lidocaine versus prilocaine on intraoperative hemodynamics, surgical field and analgesia.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Patients with pituitary adenoma undergoing endoscopic hypophysectomy.
  • ASA physical status I and II.
  • Age above 21, below 45 years.
  • Male or female
Exclusion Criteria
  • Any patient below 21 years or above 45 years.

  • Patients suffering from any of the following conditions:

    • Disturbed conscious level.
    • Coagulation abnormalities.
    • Poorly controlled blood pressure and/or heart rate.
    • Increased intracranial tension.
    • Liver and kidney disorders.
  • Patients on anticoagulants and/or NSAIDS (non-steroidal anti- inflammatory drugs

  • Patients addicted to drugs and/or alcohol.

  • Patients with disturbed conscious level at the end of the surgery, GCS >14

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
MAPMean arterial blood pressure in mmhg after 5 minutes of nasal dissection

mean arterial blood presssure 5 minutes after nasal dissection

Secondary Outcome Measures
NameTimeMethod
Mean arterial blood pressureBefore induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

Mean arterial blood pressure in mmhg before induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

Systolic blood pressureSystolic blood pressure in mmhg before induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

Systolic blood pressure before induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

Diastolic blood preesureDiastolic blood pressure in mmhg before induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

Diastolic blood pressure before induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

HRHeart rate in beats/min before induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

Heart rate before induction of Anesthesia, Before the block, 15 minutes after the block, 5 min of nasal dissection and every 30 minutes till the end of operation.

Patients needing propranololThe number of patients throughout the study in the intraoperative period who received propranolol

The number of patients needing propranolol in each group.

Propranolol neededThe amount of propranolol in mg used throughout the surgery in each group

The total amount of propranolol in mg used in each group

Patients needing phentolamineThe number of patients receiving phentolamine throughout the surgery in both groups

The number of patients needing phentolamine in each group.

Phentolamine neededThroughout the surgical time from the begining to the end of surgery

The total amount of phentolamine in mg used in each group.

Surgeon satisfaction scale10 minutes after the end of surgery.

Surgeon satisfaction scale based on Average category scale (ACS) from 0 to 5 with 0 meaning no bleeding and 5 massive uncontrollable bleeding

Time to 1st analgesic requirementThe time in hours from emergence of anaesthesia till the request of first rescue analgesia in the first 24 hours after surgery

The time from emergence of anaesthesia till the request of first rescue analgesia

Blood lossThroughout the surgical time from the begining to the end of surgery

The total ammount of blood loss in cc

Requirement for transfusionThroughout the surgical time from the begining to the end of surgery

The number of patients requiring transfusion

Fentanyl neededThroughout the surgical time from the begining to the end of surgery

number of patients needing fentanyl boluses intraoperatively

Total amount of fentanylThroughout the surgical time from the begining to the end of surgery

total ammount of fentanyl needed in micrograms

Trial Locations

Locations (1)

Kasr El Ainy

🇪🇬

Cairo, Egypt

Kasr El Ainy
🇪🇬Cairo, Egypt
Rania Fahmy, Associate Professor
Contact
+201270820372
ransam98@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.